相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Cognitive impairment in schizophrenia: aetiology, pathophysiology, and treatment
Robert A. McCutcheon et al.
MOLECULAR PSYCHIATRY (2023)
Long-acting antipsychotics in the treatment of schizophrenia: opportunities and challenges
Peter M. Haddad et al.
EXPERT OPINION ON PHARMACOTHERAPY (2023)
Effects of empowerment-based illness management on the medication adherence and recovery of persons with schizophrenia: A systematic review and meta-analysis
Wen-Ling Hsieh et al.
INTERNATIONAL JOURNAL OF MENTAL HEALTH NURSING (2023)
Schizophrenia: One Name, Many Different Manifestations
Justin Faden et al.
MEDICAL CLINICS OF NORTH AMERICA (2023)
Defining recovery in schizophrenia: A review of outcome studies
Felipe Ponce-Correa et al.
PSYCHIATRY RESEARCH (2023)
Long-term efficacy of antipsychotic drugs in initially acutely ill adults with schizophrenia: systematic review and network meta-analysis
Stefan Leucht et al.
WORLD PSYCHIATRY (2023)
A Systematic Review and Meta-Analysis of the Effectiveness of Adherence Therapy and Its Treatment Duration in Patients with Schizophrenia Spectrum Disorders
I. Hsien Li et al.
PATIENT PREFERENCE AND ADHERENCE (2023)
Rapid reviews methods series: Guidance on team considerations, study selection, data extraction and risk of bias assessment
Barbara Nussbaumer-Streit et al.
BMJ EVIDENCE-BASED MEDICINE (2023)
Efficacy of oral versus long-acting antipsychotic treatment in patients with early-phase schizophrenia in Europe and Israel: a large-scale, open-label, randomised trial (EULAST)
Inge Winter-van Rossum et al.
LANCET PSYCHIATRY (2023)
Personal and Social Functioning and Health-Related Quality of Life in Patients with Schizophrenia Treated with the Long-Acting Injectable Antipsychotic Risperidone ISM
Robert Litman et al.
NEUROPSYCHIATRIC DISEASE AND TREATMENT (2023)
The effect of long-acting injectable antipsychotic medications compared with oral antipsychotic medications among people with schizophrenia: A systematic review and meta-analysis
Chizimuzo T. C. Okoli et al.
INTERNATIONAL JOURNAL OF MENTAL HEALTH NURSING (2022)
Efficacy of long-acting injectable versus oral antipsychotic drugs in early psychosis: A systematic review and meta-analysis
Lulu Lian et al.
EARLY INTERVENTION IN PSYCHIATRY (2022)
How Would You Like to Take Your Medicine 2 Times a Year? Paliperidone Palmitate Every 6 Months for the Maintenance Treatment of Schizophrenia
Justin Faden et al.
CLINICAL THERAPEUTICS (2022)
Second-Generation Antipsychotics' Effectiveness and Tolerability: A Review of Real-World Studies in Patients with Schizophrenia and Related Disorders
Michele Fabrazzo et al.
JOURNAL OF CLINICAL MEDICINE (2022)
Recent findings on subjective well-being and physical, psychiatric, and social comorbidities in individuals with schizophrenia: A literature review
Yupeng He et al.
NEUROPSYCHOPHARMACOLOGY REPORTS (2022)
Effectiveness and Quality of Life with Paliperidone Palmitate 3-Monthly in Comparison with Other Long-Acting Drugs
Rosaria Di Lorenzo et al.
NEUROPSYCHIATRIC DISEASE AND TREATMENT (2022)
Defining Rapid Reviews: a systematic scoping review and thematic analysis of definitions and defining characteristics of rapid reviews
Candyce Hamel et al.
JOURNAL OF CLINICAL EPIDEMIOLOGY (2021)
Cochrane Rapid Reviews Methods Group offers evidence-informed guidance to conduct rapid reviews
Chantelle Garritty et al.
JOURNAL OF CLINICAL EPIDEMIOLOGY (2021)
Controversies Surrounding the Use of Long-Acting Injectable Antipsychotic Medications for the Treatment of Patients with Schizophrenia
John M. Kane et al.
CNS DRUGS (2021)
Relationship between satisfaction with mental health services, personal recovery and quality of life among service users with psychosis: a cross-sectional study
Regina Skar-Froding et al.
BMC HEALTH SERVICES RESEARCH (2021)
Long-term effect of aripiprazole lauroxil on health-related quality of life in patients with schizophrenia
Joseph P. McEvoy et al.
BMC PSYCHIATRY (2021)
Real-World Evidence of the Clinical and Economic Impact of Long-Acting Injectable Versus Oral Antipsychotics Among Patients with Schizophrenia in the United States: A Systematic Review and Meta-Analysis
Dee Lin et al.
CNS DRUGS (2021)
Paliperidone Palmitate Every Three Months (PP3M) 2-Year Treatment Compliance, Effectiveness and Satisfaction Compared with Paliperidone Palmitate-Monthly (PP1M) in People with Severe Schizophrenia
Juan J. Fernandez-Miranda et al.
JOURNAL OF CLINICAL MEDICINE (2021)
Does the Psychiatrist's Use of Subjective Well-Being Measurement in People with Schizophrenia Provide a Better Alignment with the Patient's Well-Being Perception than Clinical Judgement Alone?
Warut Aunjitsakul et al.
ADMINISTRATION AND POLICY IN MENTAL HEALTH AND MENTAL HEALTH SERVICES RESEARCH (2021)
The use of long-acting Aripiprazole in a multi-center, prospective, uncontrolled, open-label, cohort study in Germany: a report on global assessment of functioning and the WHO wellbeing index
Daniel Schoettle et al.
BMC PSYCHIATRY (2020)
The American Psychiatric Association Practice Guideline for the Treatment of Patients With Schizophrenia
George A. Keepers et al.
AMERICAN JOURNAL OF PSYCHIATRY (2020)
Partial compliance with long-acting paliperidone palmitate and impact on hospitalization: a 6-year mirror-image study
Sofia Pappa et al.
THERAPEUTIC ADVANCES IN PSYCHOPHARMACOLOGY (2020)
RoB 2: a revised tool for assessing risk of bias in randomised trials
Jonathan A. C. Sterne et al.
BMJ-BRITISH MEDICAL JOURNAL (2019)
Effects on Satisfaction and Service Engagement of Paliperidone Palmitate Compared with Oral Paliperidone in Patients with Schizophrenia: An Open Label Randomized Controlled Trial
Paola Bozzatello et al.
CLINICAL DRUG INVESTIGATION (2019)
Comparison of Paliperidone Palmitate and Second-Generation Oral Antipsychotics in Terms of Medication Adherence, Side Effects, and Quality of Life
Demet Saglam Aykut
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2019)
Quality of Life in Schizophrenia: A Meta-Analysis of Comparative Studies
Min Dong et al.
PSYCHIATRIC QUARTERLY (2019)
Formulating a good research question: Pearls and pitfalls
Wilson Fandino
INDIAN JOURNAL OF ANAESTHESIA (2019)
The Relationship Between Clinical and Personal Recovery in Patients With Schizophrenia Spectrum Disorders: A Systematic Review and Meta-analysis
Robin Michael Van Eck et al.
SCHIZOPHRENIA BULLETIN (2018)
Long-Acting Injectable Second-Generation Antipsychotics: An Update and Comparison Between Agents
Michael W. Jann et al.
CNS DRUGS (2018)
Recovery from schizophrenia: is it possible?
Antonio Vita et al.
CURRENT OPINION IN PSYCHIATRY (2018)
Predictive factors of overall functioning improvement in patients with chronic schizophrenia and schizoaffective disorder treated with paliperidone palmitate and aripiprazole monohydrate
Paolo Girardi et al.
HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL (2018)
A narrative meta-synthesis of how people with schizophrenia experience facilitators and barriers in using antipsychotic medication: Implications for healthcare professionals
Martin Salzmann-Erikson et al.
INTERNATIONAL JOURNAL OF NURSING STUDIES (2018)
Redefining rapid reviews: a flexible framework for restricted systematic reviews
Annette Pluddemann et al.
BMJ EVIDENCE-BASED MEDICINE (2018)
Why do psychiatric patients stop antipsychotic medication? A systematic review of reasons for nonadherence to medication in patients with serious mental illness
Dawn I. Velligan et al.
PATIENT PREFERENCE AND ADHERENCE (2017)
Fit for purpose: perspectives on rapid reviews from end-user interviews
Lisa Hartling et al.
SYSTEMATIC REVIEWS (2017)
Clinical benefits and impact of early use of long-acting injectable antipsychotics for schizophrenia
Georgia L. Stevens et al.
EARLY INTERVENTION IN PSYCHIATRY (2016)
Cognitive function and risperidone long-acting injection vs. paliperidone palmitate in schizophrenia: a 6-month, open-label, randomized, pilot trial
Yoshiteru Takekita et al.
BMC PSYCHIATRY (2016)
LAI versus oral: A case-control study on subjective experience of antipsychotic maintenance treatment
F. Pietrini et al.
EUROPEAN PSYCHIATRY (2016)
Health-related quality of life in acute schizophrenia patients treated with RBP-7000 once monthly risperidone: An 8-week, randomized, double-blind, placebo-controlled, multicenter phase 3 study
John J. Isitt et al.
SCHIZOPHRENIA RESEARCH (2016)
How much physical activity do people with schizophrenia engage in? A systematic review, comparative meta-analysis and meta-regression
Brendon Stubbs et al.
SCHIZOPHRENIA RESEARCH (2016)
ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions
Jonathan A. C. Sterne et al.
BMJ-BRITISH MEDICAL JOURNAL (2016)
ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions
Jonathan A. C. Sterne et al.
BMJ-BRITISH MEDICAL JOURNAL (2016)
Second-generation long-acting injectable antipsychotics in schizophrenia: patient functioning and quality of life
Cristiana Montemagni et al.
NEUROPSYCHIATRIC DISEASE AND TREATMENT (2016)
Effects of first-generation antipsychotics versus second-generation antipsychotics on quality of life in schizophrenia: a double-blind, randomised study
Gerhard Gruender et al.
LANCET PSYCHIATRY (2016)
Satisfaction of immediate or delayed switch to paliperidone palmitate in patients unsatisfied with current oral atypical antipsychotics
Jun Soo Kwon et al.
INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY (2015)
The WHO-5 Well-Being Index: A Systematic Review of the Literature
Christian Winther Topp et al.
PSYCHOTHERAPY AND PSYCHOSOMATICS (2015)
A systematic review and meta-analysis of the effect of depot antipsychotic frequency on compliance and outcome
Steve Kisely et al.
SCHIZOPHRENIA RESEARCH (2015)
Metabolic syndrome in people with schizophrenia: a review
MARC DE HERT et al.
World Psychiatry (2015)
Enhancing adherence, subjective wellbeing and quality of life in patients with schizophrenia: which role for long- acting risperidone?
Cinzia Niolu et al.
THERAPEUTIC ADVANCES IN PSYCHOPHARMACOLOGY (2015)
Trust and expectation on psychiatrist and its correlation with satisfaction and adherence in patients with mental illness
Dushad Ram et al.
ARCHIVES OF CLINICAL PSYCHIATRY (2015)
Advancing knowledge of rapid reviews: an analysis of results, conclusions and recommendations from published review articles examining rapid reviews
Robin M. Featherstone et al.
SYSTEMATIC REVIEWS (2015)
Long-Acting Injectable Formulations of New-Generation Antipsychotics: A Review from a Clinical Perspective
Anna-Sophia Rauch et al.
CNS DRUGS (2013)
WHEN IS A RESEARCH QUESTION NOT A RESEARCH QUESTION?
Nancy E. Mayo et al.
JOURNAL OF REHABILITATION MEDICINE (2013)
Medication adherence in schizophrenia: factors influencing adherence and consequences of nonadherence, a systematic literature review
Kyoko Higashi et al.
THERAPEUTIC ADVANCES IN PSYCHOPHARMACOLOGY (2013)
Effects of olanzapine long-acting injection on levels of functioning among acutely ill patients with schizophrenia
Michael M. Witte et al.
CURRENT MEDICAL RESEARCH AND OPINION (2012)
Quality of life of schizophrenic patients treated with haloperidol depot and injection preparation of long-lasting risperidone
Goran Mihajlovic et al.
Srpski Arhiv za Celokupno Lekarstvo (2012)
Subjective well-being in schizophrenia as measured with the Subjective Well-Being under Neuroleptic Treatment scale: a review
Sylke Vothknecht et al.
AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY (2011)
The impact of the social network, stigma and empowerment on the quality of life in patients with schizophrenia
I. Sibitz et al.
EUROPEAN PSYCHIATRY (2011)
Influence of type of treatment on the well-being of Spanish patients with schizophrenia and their caregivers
Maria Fe Bravo-Ortiz et al.
INTERNATIONAL JOURNAL OF PSYCHIATRY IN CLINICAL PRACTICE (2011)
Association between framing of the research question using the PICOT format and reporting quality of randomized controlled trials
Lorena P. Rios et al.
BMC MEDICAL RESEARCH METHODOLOGY (2010)
Psychometric evaluation of the Medication Satisfaction Questionnaire (MSQ) to assess satisfaction with antipsychotic medication among schizophrenia patients
Margaret K. Vernon et al.
SCHIZOPHRENIA RESEARCH (2010)
Posing the research question: not so simple
Lehana Thabane et al.
CANADIAN JOURNAL OF ANAESTHESIA-JOURNAL CANADIEN D ANESTHESIE (2009)
Comparison of Patient and Clinician Perspectives in the Assessment of Antipsychotic Medication Adherence
Corrado Barbui et al.
PSYCHOPATHOLOGY (2009)
Cross-sectional and Longitudinal Relationships Between Insight and Attitudes Toward Medication and Clinical Outcomes in Chronic Schizophrenia
Somaia Mohamed et al.
SCHIZOPHRENIA BULLETIN (2009)
Symptom control, functioning and satisfaction among Swiss patients treated with risperidone long-acting injectable
Beat Nick et al.
INTERNATIONAL JOURNAL OF PSYCHIATRY IN CLINICAL PRACTICE (2006)
Long-term treatment with long-acting risperidone in Korean patients with schizophrenia
Moon-Soo Lee et al.
HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL (2006)
Barriers to employment for people with schizophrenia
R Rosenheck et al.
AMERICAN JOURNAL OF PSYCHIATRY (2006)
Reduction in psychotic symptoms as a predictor of patient satisfaction with antipsychotic medication in schizophrenia: Data from a randomized double-blind trial
Georges M. Gharabawi et al.
BMC PSYCHIATRY (2006)
Perceived functioning, well-being and psychiatric symptoms in patients with stable schizophrenia treated with long-acting risperidone for 1 year
WW Fleischhacker et al.
BRITISH JOURNAL OF PSYCHIATRY (2005)
Is quality of life associated with cognitive impairment in schizophrenia?
K Alptekin et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2005)
Psychometric validation of a generic health-related quality of life measure (EQ-5D) in a sample of schizophrenic patients
L Prieto et al.
CURRENT MEDICAL RESEARCH AND OPINION (2004)
Development and validation of a patient-based health-related quality of life questionnaire in schizophrenia:: the S-QoL
P Auquier et al.
SCHIZOPHRENIA RESEARCH (2003)
分享论文
